TNF and chronic myelogenous leukemia, BCR-ABL1 positive: Non-leukemic HSPCs from CP-CML patients showed dysregulation of inflammatory TNF-alpha and TNF-beta pathways, associated with increased SC quiescence and a possible disruption of the CML microenvironment.